Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Thomas Desrosier

See Remarks at Seres Therapeutics, Inc. (MCRB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 18SEC MCRBSeres Therapeutics, Inc. Sell Plan 828,117 held (−1%) $4.55 $373 -45.9%
May 19SEC MCRBSeres Therapeutics, Inc. Sell Plan 797,954 held (−1%) $7.53 $595 -67.3%
Feb 18SEC MCRBSeres Therapeutics, Inc. Sell Plan 787,789 held (−1%) $8.47 $661 -71.0%
Nov 18SEC MCRBSeres Therapeutics, Inc. Sell Plan 767,623 held (−1%) $17.30 $1K -85.8%
  • Sell

    See Remarks Thomas Desrosier sold $373 of MCRB at $4.55 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Thomas Desrosier sold $595 of MCRB at $7.53 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Thomas Desrosier sold $661 of MCRB at $8.47 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Thomas Desrosier sold $1K of MCRB at $17.30 — pre-scheduled 10b5-1 plan sale.